SIOP Asia 2025

Pediatric Oncology Financial Costs of Pediatric Cancer Management in Africa: Systematic Review and Meta-Analysis
Mwanvua Ngongo Laetitia • Koba Mjumbe
doi.org/10.69690/ODMJ-018-0425-2179
Pediatric Oncology Paediatric Rhabdomyosarcoma: 15-Year Experience From A Regional Cancer Centre In South India
Nishkala Rao • Jyothi M • Prakruthi Kaushik • Pooja Chebbi • Nuthan Kumar • Avinash T • Padma M • Arunakumari BS • Appaji L • Arunkumar AR
doi.org/10.69690/ODMJ-018-0425-2176
Pediatric Oncology Early Experience Using the Cog ARET0321 Protocol for the Treatment of International Retinoblastoma Staging System (IRSS) 3 in a Resource-Limited Setting
Juan Paolo Torres • Kaira Monique Osmeña • Joliza Patricia Cañeba • Gary John Mercado • Paulita Pamela Astudillo • Nonette Cupino • Catherine Lam • Ana Patricia Alcasabas
doi.org/10.69690/ODMJ-018-0425-2163
Pediatric Oncology Genetic testing for cancer predisposition syndromes in pediatric oncology: A single center experience
Maria Kurnikova • Anastasiya Salomatina • Yulia Mareeva • Maria Skvortsova • Natalia Klipinina • Elena Raykina • Liudmila Yasko
doi.org/10.69690/ODMJ-018-0425-2162
Pediatric Oncology CD19 Chimeric Antigen Receptor (CAR) T – Cell therapy with Tisagenlecleucel in Children with B-Cell Acute Lymphoblastic Leukemia: Preliminary Findings from a Tertiary Care Center
Nada Alshaikh • Rodaina Abujoub • Rimaz Mustafa • Shahbaz Memon • Ahmed Mahdi Yousif • Sami AlThubaiti • Mohammed Essa
doi.org/10.69690/ODMJ-018-0425-2157
Pediatric Oncology GLI1-Altered Mesenchymal Tumors in Pediatric Patients: A Clinical, Morphological and Molecular Analysis of Four Cases
Ilya Sidorov • Anastasia Sharlay • Vitaly Roshchin • Alexander Druy • Nina Bogatyreva • Garik Sagoyan • Dmitry Konovalov
doi.org/10.69690/ODMJ-018-0425-2150
Pediatric Oncology The Prevalence and Associated Risk Factors for Neonatal Thrombocytopenia Among Newborns Admitted to the Neonatal Intensive Care Unit
Hussain AlGhadeer • Rahmah A. Aldhahi
doi.org/10.69690/ODMJ-018-0425-2148
Pediatric Oncology Possibilities of Using the Systemic Immune-Inflammation Index in the Diagnosis, Treatment, and Prognosis of Pediatric Patients with Hodgkin’s Lymphoma During Puberty
Daniil Dzhavadov • Elena Frantsiyants • Valeria Bandovkina • Yulia Kozel • Daria Yurchenko • Olga Popovyan
doi.org/10.69690/ODMJ-018-0425-2131
Pediatric Oncology Referral Patterns, Time-To-Diagnosis (TTD), and Time-To-Treatment Initiation (TTI) in Children with Cancer: Experience from a Tertiary Care Center, King Faisal Specialist Hospital and Research Centre , Madinah, Saudi Arabia
Afshan Ashraf Aziz • Mohamed Elsaid • Viqaruddin Mohammed • Muhammad Rahil Khan • Mohammed Abdelgalil Hossieny • Mosfer Almalki • Zaib Unnissa Asif • Mashael Saud Alrashidi • Febe Valerie Belasoto Lacson • Noufah Alrashidi • Muhammad Saghir Khan
doi.org/10.69690/ODMJ-018-0425-2129
Pediatric Oncology Vulnerable and Exposed: Tuberculosis in Pediatric oncology patients- Insights from Tertiary Care Hospital in Karachi, Pakistan
Ammara Hameed • Fahad Mumtaz • Uzma Imam • Wajid Hussain
doi.org/10.69690/ODMJ-018-0425-2128
Pediatric Oncology Sharing Insights from the National Pediatric Radiotherapy Peer Review Meetings in Pakistan
Maria Tariq • Mariam Hina • Tooba Ali • Sadia Sadiq • Muneeb Uddin Karim • Rafia Toor • Ahmed Nadeem Abbasi • Asim Hafiz • Nasir Ali • Bilal Mazhar Qureshi
doi.org/10.69690/ODMJ-018-0425-2123
Pediatric Oncology The germline genetic testing in children with DICER1-associated benign and malignant tumors: A 6-year single-center experience
Maria Skvortsova • Liudmila Yasko • Margarita Teleshova • Nataliya Andreeva • Anastasiya Salomatina • Nina Gegelia • Alexander Druy • Denis Kachanov • Maria Kurnikova
doi.org/10.69690/ODMJ-018-0425-2104